A New Approach for the Patient with Erectile Dysfunction

Chairperson:

Ian Eardley¹

Speakers:

Hartmut Porst,² Ignacio Moncada,³ Béatrice Cuzin,⁴ Ian Eardley¹

1. St James’s University Hospital and Leeds General Infirmary, Leeds, UK
2. Private Institute for Urology, Andrology and Sexual Medicine, Hamburg, Germany
3. Hospital Sanitas La Zarzuela, Madrid, Spain
4. Hospices Civils of Lyon, Lyon, France

Disclosure:

Ian Eardley is a consultant and speaker for Takeda, Menarini, Lilly, Pfizer, Sanofi, and Allergan. Hartmut Porst is a consultant, speaker and/or investigator for Auxilium, Bayer Healthcare, Lilly Company, and Menarini-Group. Ignacio Moncada is a consultant, speaker and/or investigator for Lilly, Recordati, and Sobi. Béatrice Cuzin is consultant, speaker and/or investigator for Auxilium Pharmaceuticals, Inc (AUXL)/ Swedish Orphan Biovitrum AB (Sobi), Lilly, Laboratories Majorelle, Menarini, and Pierre Fabre.

Acknowledgements:

Writing assistance was provided by Dr Ana Rodríguez de Ledesma, apothecom
scopemedical Ltd.

Support:

The symposium was jointly organised and funded by Casen Recordati, Laboratories Majorelle, Sandoz International GmbH, and Takeda UK Limited. All authors received honoraria for preparation and delivery of their presentations. The publication of this article was funded by Takeda UK Limited. The views and opinions expressed are those of the authors and not necessarily of Casen Recordati, Laboratories Majorelle, Sandoz International GmbH, or Takeda UK Limited.

Citation:

EMJ Urol. 2015;3[2]:48-56. DOI/10.33590/emjurol/10314210. https://doi.org/10.33590/emjurol/10314210.

Keywords:

Urology, EAU17.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.